The Financial Times of London is calling for caution—along with standardized and modernized regulation—around AI in healthcare.
In a brief editorial published online June 21, the influential newspaper’s editorial board acknowledges several worthwhile innovations AI is bringing to Britain’s healthcare system. However, the team warns, more oversight is needed lest the technology “prove more of a liability than an asset.”
“There are clear advantages to tireless automated assistants and researchers capable of sorting through vast piles of data,” they write. “Yet there is a danger that the new technology falls into a regulatory grey area. The lack of a single bar risks companies applying various standards to products which directly affect the public.”
Read the whole thing: